Physician profile
Alecia Fields
NPI 1396164182
$3,085.13
in general payments reported to CMS, 2019-2025
15 companies · $394 in 2025
The $394 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2021: $21.19 · 2022: $49.86 · 2023: $2,407 · 2024: $99.59 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,590 · Travel and Lodging: $805 · Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,590.05 |
| Travel and Lodging | $805.16 |
| Food and Beverage | $504.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,422.98 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Biogen, INC. | $115.63 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $114.05 | 2019 | |
| Astellas Pharma US INC | $104.31 | 2024-2025 | Veozah |
| Shield Therapeutics INC | $77.29 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $68.87 | 2022-2025 | |
| Abbvie INC. | $42.53 | 2022-2025 | |
| Organon LLC | $28.55 | 2025 | Nexplanon |
| Exeltis, USA INC. | $21.19 | 2021 | |
| Hologic Sales and Service, LLC | $17.12 | 2023 | Aptima |
| Pfizer INC. | $15.47 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.38 | 2022 | |
| Boston Scientific Corporation | $14.37 | 2023 | Upsylon |
| Avanos Medical | $14.25 | 2023 | On-Q* Pump and Accessories |
| Sumitomo Pharma America, INC. | $14.14 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alecia Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.